Ensuring robust lyophilization scale-up
Presentation provides new data regarding the mechanism of the ControLyo Technology.
SP Scientific announces the on-demand popular webinar by Jake Luoma of Genentech that discusses how controlled nucleation has emerged as a technology that promises improvements in lyophilization process throughput and consistency.
In this presentation, Mr Luoma examines the benefits of the technology for high fill-volume configurations and presents new data regarding the mechanism of the ControLyo Technology. The presentation shows how gaining a more complete understanding of the mechanism of nucleation using ControLyo Technology ensures more robust freezing when scaling from the lab to commercial-scale freeze dryers.
Traditionally in lyophilization cycles, the freezing process is uncontrolled because of the random nature of the nucleation or crystal-forming process within individual vials and across vials in a freeze dryer chamber. SP Scientific's proprietary ControLyo technology, utilizes pressurization to induce nucleation while maintaining the temperature to within 1 °C of a product’s freezing point and at the same time minimizes the supercooling effect. This produces lowered product resistance with resulting benefits that include improved product uniformity, quality and yield, and depending on formulation a reduction of cycle times by as much as 40%. In contrast to other controlled nucleation techniques, ControLyo Technology process does not introduce any foreign elements which could potentially become a carrier for micro-organisms being introduced into the product vials during the freezing process.
Jacob (Jake) Luoma has been an engineer at Genentech since 2012. After he graduated from the University of Colorado Boulder with a BS in Chemical and Biological Engineering, he joined the Genentech Process Development Rotation Program. Jake then joined the Pharmaceutical Processing and Technology Development group. There, he works on a team which develops pharmaceutical drug product manufacturing processes and technologies on the pilot scale and conducts technology transfers to implement on the manufacturing scale.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance